Bioventus Stock Buy Hold or Sell Recommendation
| BVS Stock | USD 9.61 0.46 4.57% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Bioventus is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Bioventus given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Bioventus, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Bioventus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide. Note, we conduct extensive research on individual companies such as Bioventus and provide practical buy, sell, or hold advice based on investors' constraints. Bioventus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Bioventus |
Execute Bioventus Buy or Sell Advice
The Bioventus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bioventus. Macroaxis does not own or have any residual interests in Bioventus or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bioventus' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Bioventus Trading Alerts and Improvement Suggestions
| Bioventus generated a negative expected return over the last 90 days | |
| Bioventus has high historical volatility and very poor performance | |
| Bioventus has 27.34 M in debt with debt to equity (D/E) ratio of 1.17, which is OK given its current industry classification. Bioventus has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Bioventus to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 573.28 M. Reported Net Loss for the year was (33.54 M) with profit before taxes, overhead, and interest of 388.23 M. | |
| About 70.0% of Bioventus shares are held by institutions such as insurance companies | |
| Latest headline from insidermonkey.com: Bioventus Inc. Q4 2024 Earnings Call Transcript |
Bioventus Returns Distribution Density
The distribution of Bioventus' historical returns is an attempt to chart the uncertainty of Bioventus' future price movements. The chart of the probability distribution of Bioventus daily returns describes the distribution of returns around its average expected value. We use Bioventus price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bioventus returns is essential to provide solid investment advice for Bioventus.
| Mean Return | -0.21 | Value At Risk | -5.07 | Potential Upside | 4.21 | Standard Deviation | 4.12 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bioventus historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bioventus Stock Institutional Investors
The Bioventus' institutional investors refer to entities that pool money to purchase Bioventus' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Royce & Associates, Lp | 2024-12-31 | 732.2 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 642.6 K | Oberweis Asset Management Inc | 2024-12-31 | 601.7 K | Charles Schwab Investment Management Inc | 2024-12-31 | 435.3 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 427.4 K | Ophir Asset Management Pty Ltd | 2024-12-31 | 424.7 K | Renaissance Technologies Corp | 2024-12-31 | 388.7 K | Millennium Management Llc | 2024-12-31 | 370.8 K | Segall Bryant & Hamill | 2024-12-31 | 352.6 K | Essex Woodlands Health Ventures | 2024-12-31 | 13 M | Juniper Investment Co, Llc | 2024-12-31 | 6.9 M |
Bioventus Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (528K) | 3.2M | (18.6M) | (6.0M) | (16.4M) | (15.6M) | |
| Change In Cash | 22.3M | 12.4M | (67.4M) | 5.1M | 4.6M | 4.8M | |
| Free Cash Flow | 51.1M | 15.6M | (25.1M) | 8.0M | 38.8M | 40.7M | |
| Depreciation | 28.6M | 34.9M | 66.8M | 57.4M | 49.6M | 42.1M | |
| Other Non Cash Items | 3.5M | 6.1M | 182.8M | 82.0M | 38.8M | 38.7M | |
| Capital Expenditures | 20.7M | 7.4M | 11.5M | 7.4M | 1.0M | 955.7K | |
| Net Income | 14.7M | 9.6M | (213.4M) | (121.2M) | (33.5M) | (35.2M) | |
| End Period Cash Flow | 86.8M | 99.2M | 31.8M | 37.0M | 41.6M | 51.1M | |
| Dividends Paid | 9.1M | 19.9M | 367K | 3.4M | 3.0M | 5.5M | |
| Investments | (20.5M) | (13.5M) | (116.4M) | 13.0M | 23.0M | 24.1M |
Bioventus Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bioventus or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bioventus' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bioventus stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.26 | |
β | Beta against Dow Jones | -0.38 | |
σ | Overall volatility | 4.19 | |
Ir | Information ratio | -0.03 |
Bioventus Volatility Alert
Bioventus exhibits very low volatility with skewness of 2.9 and kurtosis of 15.85. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bioventus' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bioventus' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bioventus Fundamentals Vs Peers
Comparing Bioventus' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bioventus' direct or indirect competition across all of the common fundamentals between Bioventus and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bioventus or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bioventus' fundamental indicators could also be used in its relative valuation, which is a method of valuing Bioventus by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bioventus to competition |
| Fundamentals | Bioventus | Peer Average |
| Return On Equity | -0.22 | -0.31 |
| Return On Asset | 0.0324 | -0.14 |
| Profit Margin | (0.06) % | (1.27) % |
| Operating Margin | 0.07 % | (5.51) % |
| Current Valuation | 930.47 M | 16.62 B |
| Shares Outstanding | 66.16 M | 571.82 M |
| Shares Owned By Insiders | 11.44 % | 10.09 % |
| Shares Owned By Institutions | 69.86 % | 39.21 % |
| Number Of Shares Shorted | 867.79 K | 4.71 M |
| Price To Earning | 6.96 X | 28.72 X |
| Price To Book | 4.30 X | 9.51 X |
| Price To Sales | 1.11 X | 11.42 X |
| Revenue | 573.28 M | 9.43 B |
| Gross Profit | 388.23 M | 27.38 B |
| EBITDA | (49.55 M) | 3.9 B |
| Net Income | (33.54 M) | 570.98 M |
| Cash And Equivalents | 34.36 M | 2.7 B |
| Cash Per Share | 0.56 X | 5.01 X |
| Total Debt | 27.34 M | 5.32 B |
| Debt To Equity | 1.17 % | 48.70 % |
| Current Ratio | 0.94 X | 2.16 X |
| Book Value Per Share | 2.25 X | 1.93 K |
| Cash Flow From Operations | 38.8 M | 971.22 M |
| Short Ratio | 3.29 X | 4.00 X |
| Earnings Per Share | (0.52) X | 3.12 X |
| Price To Earnings To Growth | 2.14 X | 4.89 X |
| Target Price | 15.0 | |
| Number Of Employees | 930 | 18.84 K |
| Beta | 0.86 | -0.15 |
| Market Capitalization | 635.77 M | 19.03 B |
| Total Asset | 727.96 M | 29.47 B |
| Retained Earnings | (355.08 M) | 9.33 B |
| Working Capital | 65.21 M | 1.48 B |
Note: Disposition of 9925 shares by Dadamio Anthony of Bioventus subject to Rule 16b-3 [view details]
Bioventus Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bioventus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bioventus Buy or Sell Advice
When is the right time to buy or sell Bioventus? Buying financial instruments such as Bioventus Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bioventus in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Rentals Thematic Idea Now
Rentals
Companies providing rental and leasing services to public and business. The Rentals theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rentals Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Bioventus Stock Analysis
When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.